The GP1000 and the Push for Scalable Genomics Infrastructure

GP1000 High-Throughput NGS Sequencing System | Dual-Chip DNA Sequencer

The practical demand in modern sequencing labs is no longer about whether a machine can sequence a genome, but how many genomes it can process in a single run without compromising accuracy. The GP1000 responds to this pressure with a dual-chip architecture that allows facilities to tune throughput according to batch size and project complexity. Two independent flow cells mean a lab can run distinct experiments in parallel, or double down on a single large-scale project by activating both chips simultaneously.

Peak output reaches up to two terabases per run, placing the GP1000 in the upper tier of benchtop-to-mid-range sequencers. That volume is not just a headline number; it translates directly to practical economics. For a facility processing whole-genome sequencing at 30x coverage, a single instrument run can handle dozens of human genomes, compressing timelines that once required multiple machine cycles or outsourced services.

Accuracy is often the silent cost in high-throughput workflows. Base-call quality scores above Q40 for more than 85% of reads mean fewer post-sequencing error corrections and less computational overhead during alignment and variant calling. For clinical environments where false positives or missed variants carry real consequences, this reduces the validation burden on bioinformatics pipelines.

The system supports both DNA and RNA sequencing, which is more than a check-box feature. It reflects an operational reality: many labs rotate between whole-genome, exome, and transcriptome projects, and a single platform that handles all three reduces equipment redundancy and service contracts. The simplified workflow and user interface, while rarely a headline spec, lowers the training cost for new operators and cuts the likelihood of protocol drift across shifts.

For procurement teams in research institutions and biotech firms, the GP1000 represents a specific tier of infrastructure: one that bridges the gap between entry-level sequencers and the industrial-scale systems that require dedicated facilities and specialized support. It is a machine designed for the mid-to-high throughput lab that values uptime and consistency over absolute maximum output.

China’s role in this segment is worth noting. The GP1000 enters a market where domestic manufacturers are increasingly competing with established foreign suppliers by focusing on modularity and service responsiveness. For labs operating outside major logistics hubs, local support and faster reagent supply chains are not secondary considerations — they are determinants of whether a platform stays productive.

What the GP1000 reveals is that the genomics hardware market is maturing from a contest of peak specifications into a competition of operational fit. The machine that runs reliably, adapts to mixed workloads, and fits into existing lab workflows will be the one that scales — not necessarily the one with the single highest number on the spec sheet.

Why it matters:
For labs facing growing sample volumes and tighter budgets, the GP1000 reduces the cost-per-genome through parallel processing and high accuracy. It also represents a shift in China’s sequencing equipment landscape toward systems built for reliability and workflow integration rather than raw speed alone.

View Product →